Innuendo and hinting at fake information in news coverage is enough to fuel belief in conspiracy theories, new research shows.
NUS pharmaceutical scientists have discovered the mechanisms involved when small chemical modifications to certain pharmaceutical drugs may cause harm instead of improving treatment.
Teva Pharmaceutical Industries Ltd., the world's largest generic drugmaker, on Thursday said it would lay off over a quarter of its workforce as part of a global restructuring meant to salvage its ailing business.
Antidepressants are making their way into our lakes and rivers—and they're making freshwater fish less fazed by predators.
The team led by Professor Dr. Klaus Kümmerer has now succeeded in developing antibiotics of this class of substances that become innocuous in the environment by natural degradation.
Allergan, the drugmaker behind Botox, is using an unprecedented tactic to protect its valuable patents – angering lawyers and politicians, and keeping the price of its medicines high.
The development of a new technique for labelling the body's own transporters—exosomes—could have long term benefits in the treatment of life-threatening medical conditions, including cancer.
A fascinating insight paper, "Towards pesticidovigilance" published in Science today by Dr Alice Milner, Lecturer in Physical Geography at Royal Holloway and Professor Ian Boyd (School of Biology, University of St Andrews), ...
Eli Lilly will cut 3,500 jobs and close some drug manufacturing and research facilities in a cost-cutting drive, the US pharmaceutical company announced Thursday.